{"component": "definition", "props": {"groups": [{"snippet_links": [], "samples": [{"hash": "6IdrZUhYqtf", "uri": "/contracts/6IdrZUhYqtf#potential-claims", "label": "Stock Purchase Agreement (Gates Global Inc.)", "score": 24.9753593429, "published": true}, {"hash": "AAuJ14MpNt", "uri": "/contracts/AAuJ14MpNt#potential-claims", "label": "Stock Purchase Agreement (Pinafore Holdings B.V.)", "score": 24.2169746749, "published": true}], "snippet": "has the meaning specified in Section 9.2(c).", "size": 5, "hash": "5de24b849eda6f23fb62ce4d57668fc0", "id": 1}, {"snippet_links": [], "samples": [{"hash": "5rh2uZ2qWKJ", "uri": "/contracts/5rh2uZ2qWKJ#potential-claims", "label": "Exclusive License Agreement (Alaunos Therapeutics, Inc.)", "score": 34.3524982888, "published": true}, {"hash": "7uCe0sLUUrW", "uri": "/contracts/7uCe0sLUUrW#potential-claims", "label": "Exclusive License Agreement (Ziopharm Oncology Inc)", "score": 29.8542094456, "published": true}, {"hash": "4Kfq92A4c0R", "uri": "/contracts/4Kfq92A4c0R#potential-claims", "label": "Exclusive License Agreement (Intrexon Corp)", "score": 29.8514715948, "published": true}], "snippet": "has the meaning set forth in Section 3.4(a).", "size": 3, "hash": "275033194e6c18e026f4423f6c3e9270", "id": 2}, {"snippet_links": [], "samples": [{"hash": "fbir7BeMpF4", "uri": "/contracts/fbir7BeMpF4#potential-claims", "label": "Purchase Agreement", "score": 31.340862423, "published": true}, {"hash": "kw0GGyPQlky", "uri": "/contracts/kw0GGyPQlky#potential-claims", "label": "Purchase Agreement (Hub Group, Inc.)", "score": 29.6789869952, "published": true}], "snippet": "has the meaning set forth in Section 6.2(b).", "size": 3, "hash": "2169ec83c6716522e167375abc0ae700", "id": 3}, {"snippet_links": [{"key": "claims-of", "type": "clause", "offset": [33, 42]}, {"key": "without-limitation", "type": "clause", "offset": [87, 105]}], "samples": [{"hash": "eWFvyrhryXQ", "uri": "/contracts/eWFvyrhryXQ#potential-claims", "label": "Agreement to Facilitate Dispute Resolution (Tri Valley Corp)", "score": 20.2183436003, "published": true}, {"hash": "4V7oLsUQdQc", "uri": "/contracts/4V7oLsUQdQc#potential-claims", "label": "Agreement to Facilitate Dispute Resolution (Tri Valley Corp)", "score": 20.2183436003, "published": true}], "snippet": "means, collectively, any and all claims of any and every nature whatsoever, including, without limitation, direct, derivative, class and representative claims.", "size": 2, "hash": "b0ae6dae6443990922cf17f4b5dafa50", "id": 4}, {"snippet_links": [{"key": "all-claims", "type": "clause", "offset": [14, 24]}, {"key": "prior-to", "type": "clause", "offset": [45, 53]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [57, 81]}, {"key": "related-party", "type": "clause", "offset": [133, 146]}, {"key": "relating-to", "type": "definition", "offset": [201, 212]}, {"key": "in-connection-with", "type": "clause", "offset": [229, 247]}, {"key": "the-dispute", "type": "clause", "offset": [248, 259]}, {"key": "the-license", "type": "definition", "offset": [261, 272]}, {"key": "supply-arrangement", "type": "clause", "offset": [277, 295]}, {"key": "transition-agreement", "type": "definition", "offset": [304, 324]}], "samples": [{"hash": "crqkayHNIo2", "uri": "/contracts/crqkayHNIo2#potential-claims", "label": "Settlement Agreement", "score": 31.340862423, "published": true}, {"hash": "8lX9MTbpDyH", "uri": "/contracts/8lX9MTbpDyH#potential-claims", "label": "Settlement Agreement (Mannkind Corp)", "score": 28.2032854209, "published": true}], "snippet": "means any and all Claims arising or accruing prior to or as of the Effective Date against any Sanofi Entity or any MK Entity (or any Related Party thereof) of any nature, including those arising from, relating to, based upon, or in connection with the Dispute, the License and Supply Arrangement, or the Transition Agreement.", "size": 2, "hash": "b5a242517afcb806f116ff5d16fc8a9b", "id": 5}, {"snippet_links": [{"key": "precigen-impact-situation", "type": "definition", "offset": [51, 76]}, {"key": "precigen-indemnitees", "type": "definition", "offset": [129, 149]}, {"key": "section-82", "type": "clause", "offset": [180, 191]}, {"key": "product-infringement", "type": "definition", "offset": [199, 219]}, {"key": "nk-cells-and-gamma-delta-t-cell-program", "type": "definition", "offset": [327, 366]}, {"key": "all-approvals", "type": "clause", "offset": [401, 414]}, {"key": "necessary-for", "type": "definition", "offset": [424, 437]}, {"key": "sale-of-product", "type": "clause", "offset": [453, 468]}, {"key": "applicable-field", "type": "definition", "offset": [476, 492]}, {"key": "regulatory-jurisdiction", "type": "definition", "offset": [515, 538]}, {"key": "regulatory-authority", "type": "definition", "offset": [546, 566]}, {"key": "applicable-governmental-authority", "type": "definition", "offset": [620, 653]}, {"key": "regulatory-materials", "type": "clause", "offset": [734, 754]}, {"key": "regulatory-applications", "type": "definition", "offset": [762, 785]}, {"key": "regulatory-approvals", "type": "definition", "offset": [862, 882]}, {"key": "filings-made", "type": "clause", "offset": [896, 908]}, {"key": "to-develop", "type": "definition", "offset": [987, 997]}, {"key": "licensed-product", "type": "clause", "offset": [1054, 1070]}, {"key": "released-claims", "type": "definition", "offset": [1180, 1195]}, {"key": "clinical-studies", "type": "clause", "offset": [1268, 1284]}, {"key": "sleeping-beauty-intellectual-property", "type": "definition", "offset": [1360, 1397]}, {"key": "third-party", "type": "clause", "offset": [1496, 1507]}, {"key": "covenant-not-to-sue", "type": "clause", "offset": [1530, 1549]}, {"key": "forbearance-agreement", "type": "clause", "offset": [1551, 1572]}, {"key": "agreement-or", "type": "definition", "offset": [1587, 1599]}, {"key": "rights-licensed", "type": "clause", "offset": [1661, 1676]}, {"key": "gamma-delta-t-cells", "type": "definition", "offset": [1797, 1816]}, {"key": "exclusive-product", "type": "definition", "offset": [1870, 1887]}, {"key": "biological-product", "type": "definition", "offset": [1899, 1917]}, {"key": "tcr-exclusive-program", "type": "definition", "offset": [2084, 2105]}, {"key": "research-and-development", "type": "definition", "offset": [2129, 2153]}, {"key": "designed-for", "type": "definition", "offset": [2181, 2193]}], "samples": [{"hash": "cgnTqin67Fs", "uri": "/contracts/cgnTqin67Fs#potential-claims", "label": "Exclusive License Agreement (Precigen, Inc.)", "score": 31.6016427105, "published": true}, {"hash": "89CPIrgeanb", "uri": "/contracts/89CPIrgeanb#potential-claims", "label": "Exclusive License Agreement (Precigen, Inc.)", "score": 31.3524982888, "published": true}], "snippet": "has the meaning set forth in Section 3.4(a). 1.65 \u201cPrecigen Impact Situation\u201d has the meaning set forth in Section 6.2(a). 1.66 \u201cPrecigen Indemnitees\u201d has the meaning set forth in Section 8.2. 1.67 \u201cProduct Infringement\u201d has the meaning set forth in Section 6.3(b). 1.68 \u201cProgram\u201d means, as applicable, the TCR Program and the NK Cells and Gamma Delta T Cell Program. 1.69 \u201cRegulatory Approval\u201d means all approvals that are necessary for the commercial sale of product in the applicable field in a given country or regulatory jurisdiction. 1.70 \u201cRegulatory Authority\u201d means, in a particular country or jurisdiction, any applicable Governmental Authority involved in granting Regulatory Approval in such country or jurisdiction. 1.71 \u201cRegulatory Materials\u201d means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals and/or other filings made to, received from or otherwise conducted with a Regulatory Authority in order to Develop, manufacture, market, sell or otherwise Commercialize a Licensed Product in a particular country or jurisdiction. 1.72 \u201cReleasees\u201d has the meaning set forth in Section 3.4(a). 1.73 \u201cReleased Claims\u201d has the meaning set forth in Section 3.4(a). 1.74 \u201cResearch\u201d means non-clinical studies of a product conducted before the filing of an IND for such product. 1.75 \u201cSleeping Beauty Intellectual Property\u201d means patent families [*****] and [*****] as detailed in Exhibit A. 1.76 \u201cSublicensee\u201d means any Third Party granted a sublicense, covenant not to sue, forbearance agreement, co-promotion agreement or other similar arrangement (a \u201cSublicense\u201d) by Alaunos to the rights licensed to Alaunos under Section 2.1(a) or Section 2.1(b). 1.77 \u201cT-Cell\u201d means a T-lymphocyte, including alpha beta T cells and gamma delta T cells. 1.78 \u201cTCR\u201d means T-cell receptor complex. 1.79 \u201cTCR Exclusive Product\u201d means any biological product, process or therapy that includes a TCR for a Neo-antigen, including all forms, formulations, presentations, doses, administrations and package configurations. 1.80 \u201cTCR Exclusive Program\u201d means a program(s) of Research and Development focused on Developing TCRs designed for Neo-antigens.", "size": 2, "hash": "32d5314eec9b450e01866c437cb2e647", "id": 6}, {"snippet_links": [{"key": "claims-against-the-company", "type": "clause", "offset": [20, 46]}, {"key": "pacific-life", "type": "definition", "offset": [57, 69]}, {"key": "securities-purchase-agreement", "type": "definition", "offset": [85, 114]}, {"key": "fee-agreements", "type": "definition", "offset": [123, 137]}], "samples": [{"hash": "hmszJZLa562", "uri": "/contracts/hmszJZLa562#potential-claims", "label": "Waiver and Amendment (Prison Realty Trust Inc)", "score": 18.0, "published": true}, {"hash": "2WWsaCpnMIx", "uri": "/contracts/2WWsaCpnMIx#potential-claims", "label": "Waiver and Amendment (Prison Realty Trust Inc)", "score": 18.0, "published": true}], "snippet": "means the potential claims against the Company under the Pacific Life Agreement, the Securities Purchase Agreement and the Fee Agreements.\"", "size": 2, "hash": "93239dc6382492177cfb63beb4cb2ee5", "id": 7}, {"snippet_links": [{"key": "causes-of-action", "type": "clause", "offset": [67, 83]}, {"key": "including-without-limitation", "type": "clause", "offset": [95, 123]}, {"key": "claims-for", "type": "clause", "offset": [124, 134]}, {"key": "invasion-of-privacy", "type": "clause", "offset": [135, 154]}], "samples": [{"hash": "iWl8eyAwNF4", "uri": "/contracts/iWl8eyAwNF4#potential-claims", "label": "Appearance Release and Authorization", "score": 28.8381945892, "published": true}, {"hash": "2qBLyEwG1vA", "uri": "/contracts/2qBLyEwG1vA#potential-claims", "label": "Appearance Release and Authorization", "score": 22.6516084873, "published": true}], "snippet": "mean any liability, damages (compensatory or punitive), claims, or causes of action whatsoever including without limitation claims for invasion of privacy, defamation of character or any alteration, distortion or illusionary effect, whether intentional or otherwise.", "size": 2, "hash": "da6202ee1fdaeccf2a46c55d0311c796", "id": 8}, {"snippet_links": [{"key": "the-recitals", "type": "clause", "offset": [29, 41]}], "samples": [{"hash": "hkfJSTKNW73", "uri": "/contracts/hkfJSTKNW73#potential-claims", "label": "Settlement Agreement (Pitney Bowes Inc /De/)", "score": 35.6036960986, "published": true}], "snippet": "has the meaning set forth in the recitals.", "size": 2, "hash": "e05541a00eeb1dba3509f49353d2d7e5", "id": 9}, {"snippet_links": [{"key": "claims-against-the-company", "type": "clause", "offset": [20, 46]}, {"key": "pacific-life", "type": "definition", "offset": [57, 69]}, {"key": "securities-purchase-agreement", "type": "definition", "offset": [85, 114]}, {"key": "fee-agreements", "type": "definition", "offset": [123, 137]}], "samples": [{"hash": "hmszJZLa562", "uri": "/contracts/hmszJZLa562#potential-claims", "label": "Waiver and Amendment (Prison Realty Trust Inc)", "score": 18.0, "published": true}], "snippet": "means the potential claims against the Company under the Pacific Life Agreement, the Securities Purchase Agreement and the Fee Agreements.", "size": 1, "hash": "4990c2a6e7d47dcf1d3a1f997e56ec61", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZcG90ZW50aWFsLWNsYWltcyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "has the meaning specified in Section 9.2(c).", "title": "Potential Claims", "size": 26, "id": "potential-claims", "examples": ["The Parties agree that it is in their mutual best interests to waive such PPA and Related <strong>Potential Claims</strong> and to release each other from liability thereunder.", "This Release of All Claims and <strong>Potential Claims</strong> (\u201cRelease\u201d) is entered into by and between (\u201cExecutive\u201d) and ICF International, Inc.", "This Release of All Claims and <strong>Potential Claims</strong> (\u201cRelease\u201d) is entered into by and between (\u201c \u201d) and AeroVironment, Inc., a Delaware corporation (hereinafter the \u201cCompany\u201d).", "The FDIC Receiver has allocated no more than One Hundred Twenty Five Million Dollars ($125,000,000.00) of the consideration to be received by the FDIC Receiver pursuant to the Plan and Sections 2.4 and 2.26 hereof to the FDIC Receiver\u2019s release of the <strong>Potential Claims</strong>.", "Spoliation- Notice of <strong>Potential Claims</strong> Each party shall promptly notify the other party of all potential third party claims that arise or result from this Contract.", "<strong>Potential Claims</strong> identified by Contractor that have been identified by the City before the date the Claims list is submitted may be excluded by the Director and will not result in any compensation to the Contractor.", "Employee acknowledges, and the other Releasing Parties will be deemed to have acknowledged, that they may hereafter discover facts which are different from or in addition to those that they may now know or believe to be true with respect to any and all <strong>Potential Claims</strong> herein released and agree that all such unknown <strong>Potential Claims</strong> are nonetheless released and that this Section 3 will remain effective in all respects even if such different or additional facts are subsequently discovered.", "This Release of All Claims and <strong>Potential Claims</strong> (\u201cRelease\u201d) is entered into by and between (\u201c \u201d) and Science Applications International Corporation (hereinafter \u201cSAIC\u201d).", "Employee represents and warrants to the Released Parties that neither Employee nor any Releasing Party has made an assignment or transfer of any of the <strong>Potential Claims</strong> for any Released Matter.", "With respect to any and all <strong>Potential Claims</strong> for any Released Matter, Employee expressly waives and relinquishes, and the other Releasing Parties will be deemed to have expressly waived and relinquished, any and all provisions, rights and benefits conferred by any law of any other jurisdiction or principle of common law that provides that a general release does not extend to claims that are unknown or unsuspected to the releasor at the time the releaser executes the release."], "related": [["environmental-claims", "Environmental Claims", "Environmental Claims"], ["litigation-claims", "Litigation Claims", "Litigation Claims"], ["claims", "Claims", "Claims"], ["unresolved-claims", "Unresolved Claims", "Unresolved Claims"], ["environmental-claim", "Environmental Claim", "Environmental Claim"]], "related_snippets": [], "updated": "2025-07-07T00:16:39+00:00"}, "json": true, "cursor": ""}}